How Professor Ken Witwer’s Lab at Johns Hopkins Is Revising Assumptions About Extracellular Vesicles July 30, 2026 Exosomes / Extracellular Vesicles, Interview
What Does It Take to Engineer MSCs into a Scalable Immunotherapy? June 17, 2026 BioEconomy, Cell Therapy, Interview
How DSP Decisions Shape Scale, Yield, & Cost of Goods in Exosome Preparation May 20, 2026 Biomanufacturing, Exosomes / Extracellular Vesicles
RoosterBio’s New Passages to San Juan (ISEV), Dublin (ISCT), & Montréal (ISSCR) at 2026… April 22, 2026 Conference Highlights
Critical Process Parameters in Primary Cell Manufacturing: Why & How They Matter for MSCs or Human… April 13, 2026 Biomanufacturing, Quality & Regulatory
MSC-EV Characterization Q&A: CD73, Downstream Processing, & Scalable Manufacturing Answered April 01, 2026 Bioprocessing, Exosomes / Extracellular Vesicles
From Form to Function, What Does EV Content Really Tell Us? February 26, 2026 Exosomes / Extracellular Vesicles
“More Than Luck” with 2025 Regenerative Medicine Publications Accelerated by RoosterBio January 29, 2026 Cell Therapy, Exosomes / Extracellular Vesicles, Genetic Engineering, MSCs & Characterization
ChatGPT Returns with a RoosterBio Interview to Ring in the New Year January 08, 2026 BioEconomy, Corporate
